HeartBEATS from Lifelong Learning™

Metabolic disease is increasingly recognized as a complex, multisystem condition with implications across the liver, cardiovascular system, and beyond. This relevant program guides clinicians through practical strategies to identify and manage metabolic dysfunction, including MASLD/MASH, using accessible tools such as HgA1c, ASCVD risk estimation, CKD staging, and noninvasive fibrosis scores. Our skilled experts highlight newly approved pharmacotherapies and their systemic impact, supporting a more coordinatied, whole-patient approach to care.

This video explores the evolving burden of shingle from epidemiology and clinical impact to risk factors and complications—while also looking ahead to how healthcare systems can shift toward more proactive, prevention-focused strategies to reduce its impact. Claim credit at https://bit.ly/45w36Tu

Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are rapidly increasing in prevalence, driven by rising rates of obesity, insulin resistance, and other metabolic risk factors. Faculty will review zthe physiologic roles of glucagon and incretin receptor signaling and explan how emerging therapies modulate these pathways to improve liver and cardiometabolic outcomes. Join this program to stay current and gain practical guidance to help improve the care of patients with MASLD/MASH.

CE credits available.

Learn strategies to address barriers, disparities, and inequities in shingles vaccination. It also reviews the effectiveness of clinical interventions—such as reminder systems and standing orders—in improving completion of the two-dose zoster vaccine series.

To Claim CE Credit: https://bit.ly/4xMAodX

Experts highlight shared responsibility for adult vaccination, identification of high-risk patients, and evidence-based timing of RZV, including before immunosuppressive therapy. Experts also discuss pharmacist led, technology enabled strategies that reduce missed RZV vaccination opportunities and support completion of the two-dose series through structured, team-based communication among the healthcare team to ensure coordinated care. To Claim CE Credit: https://bit.ly/4tTYVuy

Metabolic dysfunction-associated steatotic liver disease (MASLD) plays a pivotal role in cardiometabolic health, driven by its bidrectional relationship with cardiovascular disease (CVD) and its impact on long-term morbidity and mortality. This interdisciplinary vodcast explores the shared pathophysiologic pathways connecting MASLD and CVD and underscores the importance of comprehensive risk evaluation. A panel of experts discusses practical, evidence-based strategies for managing MASLD, including lifestyle interventions and the evolving landscape of pharmacologic therapies. The program highlights emerging cardiometabolic agents, including GLP 1-based therapies, ande their potential to slow disease progression and reduce cardiovascular risk in affected patients. CE credits available.

Experts discuss key evidence on shingles vaccination, including efficacy, safety, and long-term protection. It compares live and recombinant vaccines, highlights clinical trial data on durability, and offers practical strategies to address vaccine hesitancy and reinforce completion of the two-dose series.

To Claim CE Credit: https://bit.ly/4mC0awu

Maternal emergencies in rural communities often occur far from obstetric services, making EMS providers the first, and sometimes only, point of care. This activity explores the unique challenges and critical responsibilities of pre‑hospital teams in managing obstetric complications, from hemorrhage and hypertensive crises to field deliveries, while addressing social determinants of health and training gaps. Learners will gain practical strategies for improving readiness, communication, and coordinated systems of care to help reduce preventable maternal morbidity and mortality.

Learn more at http://professional.heart.org/maternal-health